SecBot SecBot
SECBOTREPLAY Home › Report › SANA

SANA · Sana Biotechnology's board is seeking shareholder approval to elect…

Sana Biotechnology, Inc. · DEFA14A filed Apr 24, 2026 at 06:25 ET

At the news

NEUTRALIMPACT 4/10

DEFA14A filed Apr 24, 2026 at 06:25 ET

Sana Biotechnology's board is seeking shareholder approval to elect three Class II directors and ratify the appointment of Ernst & Young as auditors. This follows a recent board reclassification to balance director classes, indicating ongoing governance adjustments.

  • Proxy statement seeks approval for three Class II director nominees: Hans E. Bishop, Robert Nelsen, and Alise S. Reicin, M.D.
  • Proposal to ratify Ernst & Young as independent auditors for 2026.
  • Follows a recent board reclassification of Steven D. Harr from Class I to Class III to balance board classes.
  • No other business is expected at the annual meeting.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access